Study of Panitumumab in the Treatment of Carcinoid Syndrome

NCT01172717 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study never began

Conditions

Carcinoid Syndrome

Interventions

DRUG: Panitumumab

Sponsor

Boston Medical Center

Collaborators

[object Object]